Healthcare Archives - The Wire China

WuXi Waylaid

Eliot Chen — Sun, 25 Aug 2024 23:00:00 +0000

When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply chain, is the latest example of the U.S. trying to exorcize China from its supply chains, and it will have a profound effect on WuXi Apptec, the most important drugmaker American patients have never heard of.

The post WuXi Waylaid appeared first on The Wire China.

China’s Ozempic Test

Rachel Cheung — Sun, 04 Aug 2024 23:00:00 +0000

Novo Nordisk, the maker of Ozempic, has enjoyed a China boom in recent years, commanding 77 percent of the market. But that kind of dominance isn’t likely to last, and Novo Nordisk’s challengers in China — both domestic and foreign — represent significant shifts in China’s pharmaceutical scene. Rachel Cheung reports on the tipping scales.

The post China’s Ozempic Test appeared first on The Wire China.

The Fentanyl Fix

Katrina Northrop — Sun, 21 Apr 2024 23:00:00 +0000

The U.S. and China agreed to cooperate on fentanyl, but progress is proving hard to come by.

The post The Fentanyl Fix appeared first on The Wire China.

Dali Yang on the Mistakes Made In Covid’s Early Days

Andrew Peaple — Sun, 21 Apr 2024 23:00:00 +0000

The political scientist and sinologist talks about the early days of the pandemic in Wuhan, and how the Chinese authorities’ lack of transparency led the virus to spread rapidly.

The post Dali Yang on the Mistakes Made In Covid’s Early Days appeared first on The Wire China.

A Crackdown Comes for Healthcare

Katrina Northrop — Mon, 12 Feb 2024 00:00:00 +0000

Six months into a campaign to rout out corruption from the Chinese healthcare industry, many of the underlying issues in the sector remain unchanged.

The post A Crackdown Comes for Healthcare appeared first on The Wire China.

The DNA Distortion

Katrina Northrop — Mon, 05 Feb 2024 00:00:00 +0000

ANDE, a U.S. biotechnology company, promised a "faster way to a safer world" with its revolutionary rapid DNA testing machine. But by selling its innovation to China's police force and public security apparatus, it has instead invited questions about the role of U.S. technologies in China's brutal surveillance state.

The post The DNA Distortion appeared first on The Wire China.

G42’s Ties To China Run Deep

Katrina Northrop — Mon, 04 Dec 2023 00:00:00 +0000

More details on the Emirati technology firm at the nexus of China and the U.S.’s technological and geopolitical rivalry.

The post G42’s Ties To China Run Deep appeared first on The Wire China.

The Science Split?

Eliot Chen — Sun, 20 Aug 2023 23:00:00 +0000

With a landmark, 44-year-old agreement set to expire at the end of this month, the U.S. is facing one of its biggest China tests: Can the two countries overcome their respective techno-nationalisms and cooperate on the most basic science?

The post The Science Split? appeared first on The Wire China.

The Biotech Urban Legend

Grady McGregor — Sun, 23 Jul 2023 23:00:00 +0000

Once upon a time, a U.S. company and a Chinese company developed an innovative and effective treatment for cancer. Will that ever happen again?

The post The Biotech Urban Legend appeared first on The Wire China.

China’s mRNA Blockade

Grady McGregor — Mon, 30 Jan 2023 00:00:00 +0000

China had high hopes the pandemic would launch its domestic pharmaceutical industry. That didn't happen.

The post China’s mRNA Blockade appeared first on The Wire China.

China’s Bill of Health

Eliot Chen — Mon, 16 Jan 2023 00:00:00 +0000

A look at the state of China’s healthcare system, including the cost of zero-Covid.

The post China’s Bill of Health appeared first on The Wire China.

China’s Brutal COVID Winter

Nancy Qian — Mon, 16 Jan 2023 00:00:00 +0000

The precautions to reduce Covid-19 infections are simply not an option for many Chinese households.

The post China’s Brutal COVID Winter appeared first on The Wire China.

What China’s Zero-COVID Drama Foreshadows

Nancy Qian — Mon, 12 Dec 2022 00:00:00 +0000

The public’s rejection of the Chinese government's COVID rules raises the political stakes of the next controversial policy.

The post What China’s Zero-COVID Drama Foreshadows appeared first on The Wire China.

China Needs Reality-based Governance

Victor Shih — Mon, 05 Dec 2022 00:15:00 +0000

The Chinese government can still make policies that meet their citizens' expectations — but it will need to change course fast.

The post China Needs Reality-based Governance appeared first on The Wire China.

Is the Benefit of China’s Zero-COVID Policy Worth the Cost?

Shang-Jin Wei — Sun, 23 Oct 2022 23:00:00 +0000

The Chinese strategy may be more economically sound than many assume, but it is time for the country to adopt a less severe approach.

The post Is the Benefit of China’s Zero-COVID Policy Worth the Cost? appeared first on The Wire China.

BGI Shakes Up Sequencing

Garrett O'Brien — Sun, 14 Aug 2022 23:00:00 +0000

BGI has entered the American genome sequencing market for the first time, forcing scientific innovation to clash with national security.

The post BGI Shakes Up Sequencing appeared first on The Wire China.

iHealth’s Omicron Boon

Katrina Northrop — Mon, 14 Feb 2022 00:00:00 +0000

After securing contracts with the U.S. government, the Tianjin-based company's shares have surged 980 percent on the Shenzhen Stock Exchange.

The post iHealth’s Omicron Boon appeared first on The Wire China.

China’s mRNA Boost

Katrina Northrop — Mon, 03 Jan 2022 00:00:00 +0000

With a mRNA vaccine finally in trials, will China change its Covid approach?

The post China’s mRNA Boost appeared first on The Wire China.

Jasper Becker on How to Deal With China Post-Covid

David Barboza — Sun, 31 Oct 2021 23:00:00 +0000

The journalist talks about his new Wuhan book, the "quite damaging" circumstantial evidence and demanding reciprocity with China.

The post Jasper Becker on How to Deal With China Post-Covid appeared first on The Wire China.

Books for the ‘Red New Deal’

Alec Ash — Sun, 24 Oct 2021 23:00:00 +0000

The most essential China books from the last two months that add much-needed depth to the headlines.

The post Books for the ‘Red New Deal’ appeared first on The Wire China.

Biotech’s Borders

Anastasiia Carrier — Sun, 10 Oct 2021 23:00:00 +0000

Ever since being named a strategic priority in 2015, China’s biotech industry has shown remarkable progress. But in order to achieve their global ambitions, Chinese biotech companies still need one thing: the United States.

The post Biotech’s Borders appeared first on The Wire China.

Yanzhong Huang on Why China’s Strength Is Also Its Weakness

David Barboza — Sun, 06 Jun 2021 23:00:00 +0000

The global health expert talks about China's handling of Covid-19, vaccines, and why — when it comes to policy implementation — China is remarkably resilient but also fundamentally flawed.

The post Yanzhong Huang on Why China’s Strength Is Also Its Weakness appeared first on The Wire China.

Shots in the Dark

Eli Binder — Sun, 02 May 2021 23:00:00 +0000

Leaders all across the world have expressed gratitude for China’s ‘vaccine diplomacy’ — especially as the U.S. has been far less forthcoming with its vaccines. But with so little known about the Chinese vaccines — including their efficacy — some say Beijing’s strategy is a gamble.

The post Shots in the Dark appeared first on The Wire China.

Opioid Whack-a-Mole

Katrina Northrop — Sun, 02 May 2021 23:00:00 +0000

With the arrival of “iso,” Chinese drug manufacturers have found a new way to tap into America’s huge demand for opioids.

The post Opioid Whack-a-Mole appeared first on The Wire China.

Jolly Gene Giant

Brent Crane — Sun, 21 Mar 2021 23:00:00 +0000

Last April, as the world fell to Covid-19, one Chinese company was there to offer a helping hand: BGI. But the line between the biotech giant and Beijing is blurry, and experts say the importance of protecting one’s genetic data, which has been called “the new gold,” has never been more urgent.

The post Jolly Gene Giant appeared first on The Wire China.

Vaping Madness

Katrina Northrop — Mon, 15 Feb 2021 00:00:43 +0000

A three-year-old e-cigarette company from China went public on the New York Stock Exchange last month. It’s already worth $35 billion.

The post Vaping Madness appeared first on The Wire China.

China’s Emerging Vaccination Dilemma

Victor Shih — Mon, 18 Jan 2021 00:15:00 +0000

As Covid vaccinations ramp up in the rest of the world, China faces two unpalatable choices.

The post China’s Emerging Vaccination Dilemma appeared first on The Wire China.

Hao Wu on Bearing Witness in Wuhan

Katrina Northrop — Mon, 14 Dec 2020 00:00:17 +0000

The documentary filmmaker’s newest film offers a raw depiction of Wuhan hospitals during the early days of the Covid-19 outbreak.

The post Hao Wu on Bearing Witness in Wuhan appeared first on The Wire China.

China’s New Drug Procurement Program Shakes Up Big Pharma

Katrina Northrop — Mon, 07 Dec 2020 00:00:25 +0000

The new bidding system for generic drugs upends the business of global drug makers in China. The big winners have been Chinese drug makers.

The post China’s New Drug Procurement Program Shakes Up Big Pharma appeared first on The Wire China.

China’s Best Shots

Emma Bingham — Sun, 20 Sep 2020 23:00:22 +0000

A look at the five Chinese companies furthest along in the search for a Covid-19 vaccine.

The post China’s Best Shots appeared first on The Wire China.

The GSK Files

David Barboza — Sun, 21 Jun 2020 23:00:00 +0000

Ten years ago, a single whistleblower sounded the alarm on rampant corruption at GSK's China office. But while the ensuing scandal led to record fines and even prison time in China, the original whistleblower is still waiting to be heard in the States. This is their story.

The post The GSK Files appeared first on The Wire China.

Reading When Everything Has Changed

Alec Ash — Sun, 07 Jun 2020 23:00:57 +0000

Book recommendations for our swift-changing times, including the first on-the-ground account of life in Wuhan during the lockdown.

The post Reading When Everything Has Changed appeared first on The Wire China.

U.S. Invokes National Security To Keep ‘Iron Man’ Outfit At Home

Eli Binder — Sun, 31 May 2020 23:00:00 +0000

How a small company hoping to step into China’s medical market was blocked by a powerful technology gatekeeper.

The post U.S. Invokes National Security To Keep ‘Iron Man’ Outfit At Home appeared first on The Wire China.

American Hospitals Take the China Road

Katrina Northrop — Sun, 24 May 2020 18:41:18 +0000

In a Chinese medical market predicted to reach $2.4 trillion, famed U.S. clinics team up with private companies to get in on the action.

The post American Hospitals Take the China Road appeared first on The Wire China.

China and America Are Failing the Pandemic Test

Joseph S. Nye, Jr. — Sun, 19 Apr 2020 23:00:00 +0000

On transnational issues like Covid-19 and climate change, power should be a positive-sum game.

The post China and America Are Failing the Pandemic Test appeared first on The Wire China.

Is America’s Antibiotic Supply at Risk?

Gardiner Harris — Sun, 12 Apr 2020 22:07:22 +0000

The United States no longer produces crucial drugs like penicillin. Instead, China, a strategic rival, now dominates the world’s supply chain. With a global pandemic and a fraught trade war, many are wondering if China’s pharmaceutical monopoly presents a national security threat.

The post Is America’s Antibiotic Supply at Risk? appeared first on The Wire China.

Winston Lord on U.S.–China Cooperation During Covid-19

David Barboza — Sun, 12 Apr 2020 15:00:00 +0000

A veteran diplomat explains why the problems with China pre-date Trump and how the U.S. can pursue smart competition.

The post Winston Lord on U.S.–China Cooperation During Covid-19 appeared first on The Wire China.

China’s Antibiotics Dominance

Emma Bingham — Sun, 12 Apr 2020 14:39:52 +0000

By some estimates, 90 percent of the world’s supply of antibiotics originate at huge factories in China.

The post China’s Antibiotics Dominance appeared first on The Wire China.